Skip to Content


Active Substance: aliskiren
Common Name: aliskiren
ATC Code: C09XA02
Marketing Authorisation Holder: Novartis Europharm Ltd.
Active Substance: aliskiren
Status: Withdrawn
Authorisation Date: 2007-08-22
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Agents acting on the renin-angiotensin system

Therapeutic Indication

Treatment of essential hypertension.

The marketing authorisation for Riprazo has been withdrawn at the request of the marketing-authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.